Physician profile
Roy Lin
NPI 1043582315
$6,189.06
in general payments reported to CMS, 2019-2025
13 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,235 · 2020: $18.83 · 2021: $1,348 · 2022: $135 · 2023: $281 · 2024: $56.42 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,030.44 | 2019 | |
| Abbott Laboratories | $1,904.79 | 2019-2023 | Ensite, Mitraclip |
| Medtronic Vascular, INC. | $1,570.64 | 2019-2020 | |
| Boston Scientific Corporation | $350.76 | 2019-2025 | Farapulse, Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Genzyme Corporation | $117.45 | 2022 | |
| Medtronic, INC. | $49.47 | 2023-2025 | Affera Mapping System, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.25 | 2019 | |
| Cardiva Medical, INC. | $31.77 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $28.98 | 2021 | |
| Pfizer INC. | $25.50 | 2023 | |
| Baxter Healthcare | $18.70 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Terumo Medical Corporation | $13.74 | 2019 | |
| Opsens INC. | $8.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.